Background: Patients with focal cartilage defects in the knee may suffer from both pain and functional impairment. Treatment options are often insufficient. It is not known, however, to what extent their complaints affect quality of life, compared with other knee disorders. Knee Injury and Osteoarthritis Outcome Score (KOOS) is a validated global knee score suitable for comparison of patients with knee complaints attributable to different causes.
not been completely successful in relieving symptoms (Løken et al, unpublished data, 2009 ). 17, 22, 36 Cartilage injuries generate considerable costs for society. 20 Although data such as incidence, prevalence, and costs suggest the magnitude of the problem, the degree of complaints for the patients with localized cartilage defects in the knee is less well described. Complaints related to other causes of knee disabilities are better known and described (eg, those of patients with anterior cruciate ligament [ACL] ruptures, meniscal injuries, and osteoarthritis demanding surgical intervention). However, comparison of complaints among populations with different causes of knee disability has not been brought to attention in the same manner. Moreover, regardless of cause, knee disabilities may impair the patient's quality of life. The reduction in quality of life caused by localized cartilage defects in the knee has not, to our knowledge, been compared with the reduction in quality of life caused by other knee disabilities, using a verified global knee score as a common instrument for outcome measure. In a younger patient population, reduced score values of quality of life will logically be related to a significant loss of working hours and thereby increased socioeconomic costs.
The aim of this study was to evaluate the complaints of patients having localized cartilage defects in the knee by the Knee Injury and Osteoarthritis Outcome Score (KOOS) 33 and compare the extent to which they impair quality of life with other groups of patients with knee disabilities within the working population.
The hypothesis of the current study was that complaints because of localized cartilage defects in the knee reduce quality of life measured by KOOS to a different extent than those due to ACL deficiency and osteoarthritis, when comparing patients within the working population scheduled for surgery.
MATERIALS AND METHODS

Patient Data
Previously registered KOOS baseline data from patients enrolled in different knee treatment studies at 3 cooperating hospitals were included in the study and compared. The patients were 18 to 67 years of age, defined as the working population at data registration. All patients had consented to participate in the different studies. By ''baseline data,'' we mean data registered at the time the patients were included in the different studies, before any specific treatment was initiated. The data being compared were recruited from 4 different knee patient categories. In addition to the KOOS data, gender, age, and some category-specific data were registered.
Patient Category 1: Patients With Knee Osteoarthritis Enrolled for Knee Arthroplasty. Patients in this category were previously included in 1 of 2 ongoing studies on functional results after knee replacement evaluated by KOOS. One was a case series study assessing the results after unicompartmental arthroplasty (n 5 45; 22 men, 23 women; mean age 60.9 years, standard deviation [SD] 4.0) for medial osteoarthritis (OA), 27 and the other was an almost identical study assessing the results after total knee arthroplasty (n 5 19; 7 men, 12 women; mean age 60.5 years, SD 5.9). 28 The low number of total knee arthroplasties was due to the maximum age limit of 67 years. Basic inclusion criteria for the 2 studies were identical: Despite nonoperative treatment, the patients had clinical symptoms of OA, verified radiologically, to such an extent that surgery was indicated, meaning that the patient could not cope with the pain the OA was causing. Patients with unicompartmental medial OA were scheduled for unicompartmental medial knee replacement if the criteria for osteotomy were not fulfilled. The KOOS recruited for the current study was obtained the day before surgery.
Patient Category 2: Patients With Knee Osteoarthritis Enrolled for Osteotomies Around the Knee. Patients in this second category were previously included in 1 of 3 ongoing studies on functional results after osteotomies on the distal femur or the proximal tibia evaluated by KOOS-1 being a case series study assessing the results after opening-wedge proximal tibia osteotomy for medial OA (n 5 53; 32 men, 21 women; mean age 47.4 years, SD 8.1), 8 1 being a case series study assessing the results after opening-wedge distal femur osteotomy for lateral OA (n 5 23; 12 men, 11 women; mean age 48.5, SD 7.0), 7 and 1 being a randomized control trial (RCT) study comparing the results after opening-wedge and closing-wedge proximal tibia osteotomies for medial OA (n 5 25; 17 men, 8 women; mean age 49.3 years, SD 7.0) (Nerhus et al, unpublished data, 2009). The low number of patients in the latter 2 studies was because of the still-ongoing inclusion period. Basic inclusion criteria for the 3 studies were identical: Despite conservative treatment, the patients had clinical symptoms of OA, verified radiologically, to such an extent that surgery was indicated, meaning that the patient could not cope with the pain the OA was causing. Patients were recruited for osteotomies around the knee if malalignment allowed a correction angle of 5°or more and bone health was sufficient. The KOOS was completed the day before surgery. Additionally, the preoperative Lysholm score was also recorded from the third study.
Patient Category 3: Patients With Focal Cartilage Lesions Enrolled for Cartilage Surgery. Patients in this third category were previously included in 1 of 2 ongoing studies on functional results following surgical repair of fullthickness cartilage defects in the joint surfaces of the distal femur. One was an RCT comparing the results of microfracture technique versus mosaicplasty, the defect size being 2 to 6 cm 2 (n 5 28; 17 men, 11 women; mean age 31.7 years, SD 7.9), and the second was an ongoing RCT comparing implanted autologous chondrocytes versus mesenchymal stem cells in defects 1.5 to 6.0 cm 2 or TruFit (Smith & Nephew, Andover, Massachusetts) versus microfracture technique in defects less than 20 mm in diameter (n 5 38; 27 men, 11 women; mean age 34.0 years, SD 9.5). For both these studies, the age range was limited to 18 to 50 years. Basic inclusion criteria for both studies were unacceptable complaints due to the cartilage lesion, which was verified by arthroscopy, and a Lysholm score less than 80. The KOOS was completed at enrollment in the initial studies. The preoperative Lysholm score was also recorded.
Patient Category 4: Patients With ACL-Deficient Knees Enrolled for Reconstruction. Patients in this fourth category were enrolled for ACL reconstruction at 2 of the collaborating hospitals in 2008-2009. As a routine, they consented to have their data archived at the Norwegian National Knee Ligament Registry available for future studies. Only patients 18 to 67 years of age undergoing a primary reconstruction were recruited for the current study. Data from patients with additional ligament injuries were excluded. From the National Registry, data concerning additional injuries to the knee (ie, cartilage injuries and meniscal injuries) were obtained. Statistical analyses showed no differences in complaints regarding isolated ACL injuries compared with the different combinations of these additional injuries; thus the data from these subgroups of patients were included as 1 category (n 5 160; 98 men, 62 women; mean age 31.0 years, SD 9.6). The indications for primary ACL reconstruction at the 2 hospitals were identical: despite conservative treatment focusing on stability training, the patients had repetitive ''giving way'' due to the ACL deficiency. The KOOS was completed the day before surgery. Additionally, time from injury to ACL reconstruction was recorded.
Method
The KOOS is well described in the literature. 29, 30, 33 The KOOS is a 42-item self-administered, self-explanatory knee-specific questionnaire with 5 separate outcome subscales, assessing pain (9 items), other symptoms (7 items), activities of daily living (ADL) (17 items), sport and recreational function (Sport/Rec) (5 items), and knee-related quality of life (QoL) (4 items). For each item, 5 standardized answer options are given in Likert boxes of which 1 is to be marked. The answers are rated with scores from 0 to 4. Total subscale scores are calculated and missing data handled according to the users' guide (http://www.koos.nu). The subscale scores are presented separately, ranging from 0 to 100, where 100 is the best possible result to be obtained. According to the KOOS users' guide, missing data for each subscore is handled separately, thus the number of patients may vary between subscores ( Table 1) . The KOOS has been validated for patients undergoing ACL reconstruction, 33 meniscectomy, 32 and total knee replacement. 34 Recently, the KOOS has also been validated for the treatment of focal cartilage lesions. 2 The Western Ontario and McMaster Universities Osteoarthritis Index (version LK 3.0) 3 items are included in the first 3 KOOS subscales. The KOOS has been considered reliable and responsive for assessment of knee complaints in acomparative review of knee-specific outcome measures. 10 In a study comparing the degree to which different kneespecific outcome instruments included items to detect symptoms and disabilities most important to the patients, the KOOS was identified as 1 of the top 2 general knee quality-of-life instruments ensuring that the patient's perspective was considered. 38 Patient-reported outcomes assessing knee problems do, however, vary with age and gender in the general population. 6, 16 Therefore, KOOS reference data from a ''normal'' Scandinavian population was established, 30 making it possible to correct the subscales for age and gender.
The complaints of the 4 patient categories were compared in regard to each of the 5 subscales of the KOOS obtained at baseline. To evaluate to what extent the other subscales relatively affected the quality of life of the patients within each patient category, the parameter QoL was correlated to the other 4 subscales. The mean age of each category was compared. Mean Lysholm scores for the cartilage patients and the osteotomy patients were compared. The mean time from initial symptoms in the cartilage patients and mean time from injury in the ACLdeficient patients are given as descriptive information. Differences in the mean KOOS subscale QoL between groups was the primary parameter in comparing the complaints of the 4 patient categories.
Statistics
For the statistical analysis, we used SPSS version 15.0 (SPSS Inc, Chicago, Illinois). One-way analysis of variance was used for comparison of mean age between the patient categories. The data obtained from KOOS are ordinal rather than continuous. However, the sample size in each group was considered large enough to apply the central limit theorem with normally distributed sample means. One-way analysis of variance was applied for comparison between groups, supplied by post hoc Bonferroni tests due to multiple comparisons. 30 Knee-related quality of life, with the smallest number of items to be answered, was controlled by nonparametric tests that were in agreement with the analysis of variance test. Thus, the results within each subscale are given as mean values for each category supplied by the SD, and the differences between the categories as mean differences supplied by the standard error of the mean, the 95% confidence interval, and P values. The correlation between QoL and the other 4 subscales was performed by linear regression analyses. The results are given as R 2 and the corresponding P value. The comparison of Lysholm scores between the cartilage patients and the osteotomy patients was performed by an independent-sample t test.
RESULTS
The mean age and the SDs for the different patient categories are shown in Figure 1 . One-way analysis of variance revealed a significant difference in mean age between the groups. Post hoc Bonferroni tests showed significant differences to be present among all groups except between the patients with focal cartilage defects and those with ACL deficiency. The mean age in the cartilage patient category was 33.0 (95% confidence interval, 30.8-35.2) .
The values of the 5 KOOS subscales for the different patient categories are shown in Figure 2 .
One-way analysis of variance tests revealed significant differences between the patient categories for all subscales, including the QoL. The results of the post hoc Bonferroni tests comparing the different KOOS subscales of the patients with focal cartilage defects to the other patient categories are shown in Table 1 . According to the Bonferroni tests, the cartilage patients' quality of life was affected to the same extent as those of the patients with osteoarthritis enrolled for arthroplasties and osteotomies. The cartilage patients scored significantly worse (P .001) for all subscales of KOOS compared with the ACL-deficient patients. The mean time from initial symptoms to the KOOS obtained in the cartilage patient category was 70.0 months (SD 73.7), whereas the mean time from injury to surgery for the ACL-deficient patients was 26.1 months (SD 48.6). Among the ACL patient category, 12.6% had International Cartilage Repair Society (ICRS) grade 3 or 4 focal cartilage lesions in their knees.
The subscale QoL correlated significantly to all the other 4 subscales of KOOS in all patient categories except to Symptoms in the patient category of arthroplasties (R 2 5 .065; P 5 .021) ( Table 2 ). The QoL of the cartilage patients showed an equally high value of R 2 in the correlation with ADL, Sport/Rec, and pain. The QoL in ACL patients and osteotomy patients showed the highest value of R 2 in correlation with Sport/Rec, whereas the QoL in arthroplasty patients showed the highest value of R 2 in correlation with ADL ( Table 2) . The mean Lysholm score of patients with focal cartilage defects was 49.5 (SD 13.9), not significantly different from the 47.6 (SD 15.6) registered in the osteotomy patient category.
DISCUSSION
The current study showed that the quality of life of patients with focal cartilage defects in the knee is significantly affected. In fact, the patients enrolled for cartilage surgery have score values on the KOOS QoL equal to older patients with osteoarthritis signed up for knee replacement. To our knowledge, this has not been documented previously. Moreover, the cartilage patients had similar low scores on all 5 subscales of the KOOS, the scores being equal to those of the osteoarthritic patients enrolled for osteotomies around the knee. The similarity between these 2 patient categories was confirmed by the Lysholm score. Anterior cruciate ligament-deficient patients scheduled for surgical treatment, on the other hand, scored significantly higher than cartilage patients according to all 5 subscales.
Based on the correlation analyses performed, the reduction in the subscales pain, ADL, and Sport/Rec contributed equally to the reduction in QoL of the cartilage patients. For the osteotomy patients, as well as for the ACL-deficient patients, the impairment of Sport/Rec function contributed the most, whereas for the arthroplasty patient category, impaired ADL contributed most to the reduced QoL.
The patients included in this study were all scheduled for surgical interventions because of their clinical complaints. Thus, the different patient groups probably do not reflect the overall quality of life of all patients with the respective diagnoses. For example, many patients with focal cartilage defects do well and are not scheduled for surgery. The same phenomenon is valid for the other diagnoses as well, but the percentage of patients within each diagnosis enrolled for surgery may differ. We therefore would like to emphasize that the results in this study concern patients already enrolled for surgery only. One weakness of the study, however, is that the threshold of offering patients surgical treatment may vary from one type of disability to another-mainly dependent on the expected ''cost-benefit analysis'' outcome for that particular treatment. Patient populations with knee complaints such as ligament injuries and osteoarthritis are offered surgical procedures that have a high success rate in relieving symptoms, that is, ligament reconstruction for ACL injuries 31 and either osteotomies in the middle-aged patients 5, 7, 8 or joint replacement [27] [28] [29] in the elderly suffering from osteoarthritis. The results of surgical treatment for patients with localized cartilage defects in the knee (ie, cartilage repair) have been subject to controversies 22 and have not been equally successful. 11, 17, 21, 24, 25, 35 In a study by Bekkers et al, 2 40 patients were evaluated by KOOS 32 months after either microfracture or autologous chondrocyte implantation (ACI). The mean KOOS subscale QoL was 49 in both groups of patients. Moreover, despite a number of randomized controlled studies, 4, 11, 15, 18, 36 there is no consensus on a surgical technique being superior to the others-or to nonoperative treatment (Løken et al, unpublished data, 2009 ). 23, 37 In a previous arthroscopic study, 64 of 997 knees had ICRS grade 3 or 4 chondral defects. 1 Although we know that this group is heterogeneous in regard to symptoms, a 6-year follow-up study showed that these patients still have knee problems, whether they undergo cartilage surgery or not (Løken et al, unpublished data, 2009 ). The results are, however, claimed to be encouraging in younger patients. 11, 17, 25 In the present study, the mean age of the cartilage patient population was 33.0 years (95% confidence interval, 30.8-35.2 years). In the work of Knutsen et al 17, 18 comparing microfracture technique to ACI, there were significantly better results in patients below 30 years of age both at 2 and 5 years of follow-up, regardless of treatment. Best results after ACI have been shown in young, active patients with a high preoperative score, a single defect, and symptoms for less than 2 years. 19 The mean time from initial symptoms to completing the KOOS in the current study was 70.0 months (SD 73.7), whereas the median time was 37.5 months. The information on duration of symptoms before surgery is generally sparse, but in 1 RCT, the mean duration was 36 months. 18 Thirteen percent of the ACL patient population had ICRS grade 3 or 4 cartilage injuries. Our statistical analyses 12, 37, 39 These findings suggest that cartilage defects may play a minor role in ACL-deficient and ACLreconstructed knees, the mechanisms of which are not clear.
Because of the degree of complaints and reduced quality of life the cartilage patients have, an alternative treatment option could be joint arthroplasty, either as unicompartmental or total knee replacement. However, despite good results in the elderly, the results of knee replacement in the younger knee-active population are less favorable and not recommended. 9 In the current study, the patients in the cartilage category were a mean 28 years younger than the patients in the arthroplasty category, and a mean 15 years younger than the patients in the osteotomy category. In an article by Paradowski et al, 30 all the subscales of KOOS were found to be age-dependent in a ''normal'' Scandinavian population, the values of QoL declining significantly with age. In that respect, the cartilage patients are relatively even worse compared with the patients in the arthroplasty and osteotomy categories.
A major advantage of the current study is that the data were recruited from recently performed or ongoing clinical studies that ensured that the system of data collection was similar. Additionally, the same instrument was used as an evaluation measure for all patient categories. The KOOS is validated in respect to several knee disabilities. Reference data for each of the 5 subscales regarding age and gender is established. We therefore believe the KOOS is suitable for the purpose of comparing complaints of different knee patient groups. To our knowledge, the KOOS has previously never been used in such a comparison. The main purpose of this study was to determine and compare how the severity of symptoms and functional limitations together affected the different population's quality of life. Thus, in selecting 1 of the subscales as a primary outcome instrument for comparison between groups, the natural choice was QoL. The importance of using validated diseasespecific quality-of-life measures in evaluating knee patients has been emphasized by other authors as well. 26 
CONCLUSION
According to the current study, patients with focal cartilage lesions have major problems with pain and functional impairment. Their complaints are worse than those of ACL-deficient patients, and quality of life is affected to the same extent as in patients scheduled for knee replacement. On the basis of the literature, we conclude that the treatment options for cartilage patients are generally still not sufficient, implying that a number of these patients will have to cope with their complaints even after surgical cartilage repair-with the expectations of an even less favorable result if reoperations are to be performed. 19, 24 Based on the substantial number these patients represent and the degree of complaints they have, we suggest that improved treatment methods are clearly needed. 
